The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sarcopenia as a negative predictive marker for treatment with pembrolizumab as a second line in patients with metastatic non-small cell lung cancer.
 
Milla Petrova
No Relationships to Disclose
 
Gerogi Valchev
No Relationships to Disclose
 
Nikolay Vladimirov Conev
No Relationships to Disclose
 
Eleonora Dimitrova
No Relationships to Disclose
 
Bozhil Robev
No Relationships to Disclose
 
Marsella Boneva
No Relationships to Disclose
 
Boian Pavlov
No Relationships to Disclose
 
Velko Minchev
No Relationships to Disclose
 
Teodora Karanikolova
No Relationships to Disclose
 
Spartak Valev
No Relationships to Disclose
 
Radostina Gencheva
No Relationships to Disclose
 
Georgi Zhbantov
No Relationships to Disclose
 
Anika Ivanova
No Relationships to Disclose
 
Constanta Timcheva
No Relationships to Disclose
 
Ivan Donev
No Relationships to Disclose